European Medical Tourist

European Medical Tourist

“making healthcare affordable for individuals and companies”

Home | About Us | Videos & Testimonials | Services | Media | Sitemap | Contact
Latest News
Popular
Transplant
Medical Tourism arrow Transplant arrow Liver Transplant
Liver Transplant

Liver Tranplants of various types are available in Germany. All liver tranplants are done by university professors, who are especially trained in this area. Cost of kidney transplants in Germany is variable. Liver donors and kidney recipients are heavily screened and must appear before two review boards, a medical board and ethics board for approval. This is includes psychological tests. This process can take up to three months, but can be done in as little as three weeks. EMT takes the client through this process.

Because of the delays and difficulties with international visas, European Medical Tourist will attempt to facilitate liver transplants only with clients, who have a donor.

Liver Transplant: Definition

A liver transplant is the replacement of a diseased liver with a healthy liver allograft. The most commonly used technique is orthotopic transplantation, in which the native liver is removed and the donor organ is placed in the same anatomic location as the original liver. A liver transplant nowadays is a well accepted treatment option for end-stage liver disease and acute liver failure.

Liver Transplant: History

The first human liver transplant was done in 1963 by Dr. Thomas Starzl of Denver, Colorado, United States, and by Sir Roy Calne of the University of Cambridge, United Kingdom. Dr. Starzl performed several additional transplants over the next few years before the first short-term success was achieved in 1967 with the first one-year survival posttransplantation. Despite the development of viable surgical techniques, a liver transplant remained experimental through the 1970s, with one year patient survival in the vicinity of 25%. The introduction of cyclosporine by Sir Roy Calne markedly improved patient outcomes, and the 1980s saw recognition of liver transplantation as a standard clinical treatment for both adult and pediatric patients with appropriate indications. Liver transplantation is now performed at over one hundred centers in the USA, as well as numerous centers in Germany and elsewhere. One year patient survival is 85-90%, and outcomes continue to improve, although a liver transplant remains a formidable procedure with frequent complications. Unfortunately, the supply of liver allografts from non-living donors is far short of the number of potential recipients, a reality that has spurred the development of living donor liver transplantation.

Liver Transplant: Indications

A Liver transplant is potentially applicable to any acute or chronic condition resulting in irreversible liver dysfunction, provided that the recipient does not have other conditions that will preclude a successful transplant. Metastatic cancer outside liver, HIV, active drug or alcohol abuse and active septic infections are absolute contraindications. Advanced age and serious heart, pulmonary or other disease may also prevent transplantation (relative contraindications). Most liver transplants are performed for chronic liver diseases that lead to irreversible scarring of the liver, or cirrhosis.

Liver Transplant: Techniques

Before transplantation a patient can be treated with MARS-dialysis. It has albumin-circulation which filters bile acids, bilirubin, and other toxins which the diseased liver fails to clear; and normal water-circulation which can be used to help kidneys.

Virtually all liver transplants are done in an orthotopic fashion, that is the native liver is removed and the new liver is placed in the same anatomic location. The transplant operation can be conceptualized as consisting of the hepatectomy (liver removal) phase, the anhepatic (no liver) phase, and the postimplantation phase. The operation is done through a large incision in the upper abdomen. The hepatectomy involves division of all ligamentous attachments to the liver, as well as the common bile duct, hepatic artery, and portal vein. Usually, the retrohepatic portion of the inferior vena cava is removed along with the liver, although an alternative technique preserves the recipient's vena cava ("piggyback" technique). After the hepatectomy is accomplished, the allograft liver is implanted. This involves anastomoses (connections) of the inferior vena cava, portal vein, and hepatic artery. After blood flow is restored to the new liver, the biliary (bile duct) anastomosis is constructed, either to the recipient's own bile duct or to the small intestine. The surgery usually takes between five and six hours, but may be longer or shorter due to the difficulty of the operation and the experience of the surgeon.

The large majority of liver transplants use the entire liver from a non-living donor for the transplant, particularly for adult recipients. A major advance in pediatric liver transplantation was the development of reduced size liver transplantation, in which a portion of an adult liver is used for an infant or small child. Further developments in this area included split liver transplantation, in which one liver is used for transplants for two recipients, and living donor liver transplantation, in which a portion of healthy person's liver is removed and used as the allograft. Living donor liver transplantation for pediatric recipients involves removal of approximately 20% of the liver (Couinaud segments 2 and 3).

Liver Transplant: Immunosupression

Like all other allografts, a liver transplant will be rejected by the recipient unless immunosuppressive drugs are used. The immunosuppressive regimens for all solid organ transplants are fairly similar, and a variety of agents are now available. Most liver transplant recipients receive corticosteroids plus either tacrolimus or Cyclosporin.

A liver transplant is unique in that the risk of chronic rejection also decreases over time, although recipients need to take immunosuppresive medication for the rest of their lives.It is theorized that the liver may play a yet-unknown role in the maturation of certain cells pertaining to the immune system. There is at least one study by Dr. Starzl's team at the University of Pittsburgh which consisted of bone marrow biopsies taken from such patients which demonstrate genotypic chimerism in the bone marrow of liver transplant recipients.

Liver Transplant: Prognosis

Prognosis for a liver transplant is quite good. 1-year survival (in Finland) is 83%, 5-year survival is 76% and 10-year survival is 66%. Majority of deaths happen during the first three months after transplantation.

For a free evaluation of your treatment needs and cost, please contact us.

The information provided herein is not intended to be a substitute for professional medical advice.

 
< Prev
 
©2008 European Medical Tourist